Dr. Jennings brings to Biosion over 20 years of broad regulatory experience in all stages of product development within pharmaceutical and biotechnology companies.

Before joining Biosion, Dr. Jennings was the Founder and Principal Regulatory Consultant at RegPath LLC, which provides product development and regulatory support to small biotechnology companies. Prior to founding RegPath, Dr. Jennings was the SVP, Head of Regulatory Affairs at Casebia Therapeutics and served as the cross-functional Project Lead for the autoimmune/tolerance edited T regulatory cell program. Prior to Casebia, she was the SVP, Head of Regulatory at Achillion Pharmaceuticals and, earlier, served as Sanofi’s Associate Vice President for Regulatory Affairs in the company’s North American diabetes program. Before Sanofi, she held positions of increasing responsibility at Bristol-Myers Squibb.

Dr. Jennings holds a Ph.D. in Biochemistry from The Ohio State University and completed postdoctoral training at the Harvard-affiliated Joslin Diabetes Center.